baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Oragenics Inc/ US6840235005 /

6/10/2024 9:54:44 PM	Chg. 0.00	Volume	Bid-	Ask-	High	Low
1.69USD	0.00%	418 Turnover: 709.16	-Bid Size: -	-Ask Size: -	1.73	1.65

GlobeNewswire 5/22 Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer

GlobeNewswire 5/17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

GlobeNewswire 5/16 Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial

GlobeNewswire 5/7 Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia

GlobeNewswire 9/1/2020 Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developm...

GlobeNewswire 7/14/2020 Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors

GlobeNewswire 4/30/2019 Investor Expectations to Drive Momentum within H&R Block, Aercap Holdings N.V, Oragenics, and Atomer...

GlobeNewswire 6/20/2018 Diamond Equity Research Initiates Coverage on Oragenics Inc. (NYSE:OGEN) with a Valuation of $3.50 P...

GlobeNewswire 5/16/2018 Oral Proteins and Peptides Market, 2030

GlobeNewswire 6/29/2017 Rocky Mountain High Brands Announces Jerry Grisaffi’s Retirement; Gerry David Named Chairman of the ...

GlobeNewswire 4/25/2017 Rocky Mountain High Brands Appoints Award Winning CEO, Gerry David, to Its Board of Directors and Sp...

Oragenics Inc/ US6840235005 /

If you wish to receive reply to your feedback, please provide your email address.